UBS Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.4M | Sell |
212,800
-15,400
| -7% | -$1.48M | ﹤0.01% | 2682 |
|
|
2025
Q4 | $21.9M | Sell |
228,200
-21,200
| -9% | -$2.06M | ﹤0.01% | 2506 |
|
|
2025
Q3 | $23.8M | Buy |
249,400
+66,600
| +36% | +$6.12M | ﹤0.01% | 2374 |
|
|
2025
Q2 | $15.9M | Sell |
182,800
-259,200
| -59% | -$22M | ﹤0.01% | 2618 |
|
|
2025
Q1 | $39.7M | Buy |
442,000
+83,700
| +23% | +$7.49M | 0.01% | 1692 |
|
|
2024
Q4 | $28.6M | Buy |
358,300
+74,000
| +26% | +$6.41M | 0.01% | 1959 |
|
|
2024
Q3 | $25.6M | Buy |
284,300
+33,900
| +14% | +$2.85M | 0.01% | 1633 |
|
|
2024
Q2 | $19.7M | Buy |
250,400
+68,200
| +37% | +$5.59M | ﹤0.01% | 1685 |
|
|
2024
Q1 | $15.9M | Buy |
182,200
+91,800
| +102% | +$7.83M | ﹤0.01% | 1871 |
|
|
2023
Q4 | $7.45M | Buy |
90,400
+39,700
| +78% | +$3.03M | ﹤0.01% | 2356 |
|
|
2023
Q3 | $3.97M | Buy |
50,700
+300
| +0.6% | +$25.1K | ﹤0.01% | 2800 |
|
|
2023
Q2 | $4.44M | Sell |
50,400
-205,100
| -80% | -$17.7M | ﹤0.01% | 2713 |
|
|
2023
Q1 | $20.6M | Sell |
255,500
-69,700
| -21% | -$5.68M | 0.01% | 1366 |
|
|
2022
Q4 | $25.3M | Sell |
325,200
-142,900
| -31% | -$11.6M | 0.01% | 1249 |
|
|
2022
Q3 | $37.8M | Buy |
468,100
+107,200
| +30% | +$9.63M | 0.02% | 851 |
|
|
2022
Q2 | $32.4M | Sell |
360,900
-19,300
| -5% | -$1.96M | 0.01% | 1020 |
|
|
2022
Q1 | $42.2M | Buy |
380,200
+138,296
| +57% | +$14.6M | 0.01% | 948 |
|
|
2021
Q4 | $25M | Buy |
241,904
+47,110
| +24% | +$5.46M | 0.01% | 1427 |
|
|
2021
Q3 | $24.4M | Sell |
194,794
-49,100
| -20% | -$6.36M | 0.01% | 1347 |
|
|
2021
Q2 | $30.3M | Buy |
243,894
+66,400
| +37% | +$8.34M | 0.01% | 1164 |
|
|
2021
Q1 | $21M | Sell |
177,494
-306,006
| -63% | -$35.9M | 0.01% | 1417 |
|
|
2020
Q4 | $56.6M | Buy |
483,500
+460,700
| +2,021% | +$50.7M | 0.02% | 730 |
|
|
2020
Q3 | $2.37M | Buy |
22,800
+700
| +3% | +$70.3K | ﹤0.01% | 2894 |
|
|
2020
Q2 | $2.03M | Buy |
22,100
+8,700
| +65% | +$834K | ﹤0.01% | 2868 |
|
|
2020
Q1 | $1.21M | Sell |
13,400
-98,900
| -88% | -$10.5M | ﹤0.01% | 3197 |
|
|
2019
Q4 | $12.7M | Sell |
112,300
-10,700
| -9% | -$1.17M | ﹤0.01% | 1726 |
|
|
2019
Q3 | $13.4M | Sell |
123,000
-102,400
| -45% | -$10.7M | 0.01% | 1540 |
|
|
2019
Q2 | $22M | Buy |
225,400
+200,200
| +794% | +$18.3M | 0.01% | 1152 |
|
|
2019
Q1 | $2.29M | Sell |
25,200
-196,700
| -89% | -$17.6M | ﹤0.01% | 2876 |
|
|
2018
Q4 | $20.2M | Buy |
221,900
+122,700
| +124% | +$11.5M | 0.01% | 1081 |
|
|
2018
Q3 | $9.76M | Buy |
99,200
+3,900
| +4% | +$361K | ﹤0.01% | 1803 |
|
|
2018
Q2 | $8.16M | Sell |
95,300
-25,200
| -21% | -$2.1M | ﹤0.01% | 1912 |
|
|
2018
Q1 | $9.67M | Sell |
120,500
-331,000
| -73% | -$27.3M | ﹤0.01% | 1716 |
|
|
2017
Q4 | $36.5M | Buy |
451,500
+318,700
| +240% | +$25.5M | 0.02% | 827 |
|
|
2017
Q3 | $10.3M | Buy |
132,800
+70,500
| +113% | +$5.85M | ﹤0.01% | 1599 |
|
|
2017
Q2 | $5.53M | Sell |
62,300
-4,600
| -7% | -$388K | ﹤0.01% | 2062 |
|
|
2017
Q1 | $5.39M | Sell |
66,900
-57,211
| -46% | -$4.47M | ﹤0.01% | 2031 |
|
|
2016
Q4 | $8.84M | Sell |
124,111
-14,486
| -10% | -$1.14M | ﹤0.01% | 1600 |
|
|
2016
Q3 | $12M | Buy |
138,597
+29,311
| +27% | +$2.55M | 0.01% | 1293 |
|
|
2016
Q2 | $9.48M | Sell |
109,286
-88,130
| -45% | -$7.13M | 0.01% | 1421 |
|
|
2016
Q1 | $14.8M | Buy |
197,416
+176,216
| +831% | +$13.3M | 0.01% | 1074 |
|
|
2015
Q4 | $1.63M | Sell |
21,200
-132,826
| -86% | -$10M | ﹤0.01% | 2997 |
|
|
2015
Q3 | $10.3M | Sell |
154,026
-245,500
| -61% | -$18.1M | 0.01% | 1342 |
|
|
2015
Q2 | $29.6M | Buy |
399,526
+248,226
| +164% | +$19M | 0.02% | 753 |
|
|
2015
Q1 | $11.8M | Sell |
151,300
-1,881,619
| -93% | -$143M | 0.01% | 1341 |
|
|
2014
Q4 | $147M | Buy |
+2,032,919
| New | +$141M | 0.1% | 211 |
|
Other funds holding MDT
VCM
VPM
UBS Group's MDT Position: Q1 2026 in Review
UBS Group increased its Medtronic (MDT) stake by 54% in Q1 2026, buying an estimated $215M and bringing the position to 6,412,252 shares worth $556M. The position accounts for 0.08% of the portfolio, ranked #245.
UBS Group first reported a position in MDT in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.7B in Q4 2019. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- UBS Group held 6,412,252 shares of Medtronic worth $556M as of Q1 2026.
- UBS Group bought 2,241,365 Medtronic shares in Q1 2026, an estimated $215M.
- Medtronic made up 0.08% of UBS Group's portfolio in Q1 2026, its #245 holding.
- UBS Group first reported a position in Medtronic in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Medtronic position peaked at $1.7B in Q4 2019.
- 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.